Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
No clinical trials with PBF-509 in humans have been performed to date. Only preclinical
studies have been done to assess the pharmacology and pharmacokinetics, the safety and the
toxicological profile of the PBF-509.
An initial testing of PBF-509 in humans is planned, starting with the first-into-man clinical
trial where a single oral, dose-escalating, and placebo-controlled design will be
implemented.
Phase:
Phase 1
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau